Palisade Bio, Inc. ( PALI) - Stock Earnings
PALI Upcoming earnings
Estimated EPS and revenue columns are available to paid members.
| Date | EPS (actual / est.) | Revenue low (est.) | Revenue (actual / est.) | Revenue high (est.) |
|---|---|---|---|---|
| Nov. 9, 2026, midnight | — / — | — | — / — | — |
PALI Quarterly earnings
Analyst consensus estimates are available to paid members.
| Date | Earnings | Revenue |
|---|---|---|
| 2025Q4 | -8.9 million USD | — USD |
| 2026Q1 | -9.6 million USD | — USD |
| 2026Q2 | -10.6 million USD | 500000 USD |
| 2026Q4 Est. | — | — |
| 2027Q1 Est. | — | — |
| 2027Q2 Est. | — | — |
PALI Yearly earnings
Analyst consensus estimates are available to paid members.
| Date | Earnings | Revenue |
|---|---|---|
| 2023 | -12.3 million USD | 250000 USD |
| 2024 | -14.4 million USD | — USD |
| 2025 | -16.8 million USD | — USD |
| 2026 Est. | — | — |
PALI
Price: $1.41
Earnings Per Share: 0.65 USD
P/E Ratio: 3.29
Exchange: NCM
Sector: Healthcare
Industry: Biotechnology
Country: United States
Volume: 369800
Market Capitalization: 250.0 million